Search | IOVS | ARVO Journals

View

Showing 1 – 15 of 15

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

ARVO Annual Meeting Abstract June 2017

In vitro and In vivo Sustained Release of Dexamethasone from Intravitreal Implants

Janet Tully; Mari Yang; Stuart Williams; Sanjib Das; Rozemarijn S Verhoeven; RiLee Robeson; Rhett M Schiffman; Benjamin R Yerxa

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):4111. doi:

ARVO Annual Meeting Abstract June 2017

In vitro Sustained Release of Tyrosine Kinase Inhibitors from Biodegradable PRINT Implants

Melissa Sandahl; Kwadwo Caesar; Janet Tully; Mari Yang; Stuart Williams; Rhett M Schiffman; Benjamin R Yerxa

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):4458. doi:

ARVO Annual Meeting Abstract September 2016

Precision Size and Shape Extended Release Intravitreal Dexamethasone Implants

Sanjib Kiumar Das; Stuart Williams; Janet Tully; Rozemarijn S Verhoeven; Mari Yang; Tomas Navratil; Rhett Schiffman

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12):3278. doi:

ARVO Annual Meeting Abstract September 2016

In vitro and In vivo Sustained Release of Dexamethasone from a PRINT Microparticle Suspension

Melissa Sandahl; Melissa Hernandez; Janet Tully; Gary owens; Rozemarijn S Verhoeven; RiLee Robeson; Stuart Williams; Rhett Schiffman

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12):4023. doi:

ARVO Annual Meeting Abstract September 2016

Sustained Release Biodegradable Formulations for Intraocular Delivery: Extended Release of Hydrophilic APIs and Combination Products

Janet Tully; Mari Yang; Melissa Sandahl; Stuart Williams; Rhett Schiffman

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12):4029. doi:

ARVO Annual Meeting Abstract September 2016

Design and Development of ENV515 Intraocular Applicator for Intracameral Injections of ENV515 Glaucoma Extended Release (XR) Therapy

Tomas Navratil; Jessie Delgado; Andres Garcia; Gretchen Willard; Andrew Corson; Rozemarijn S Verhoeven; Leo Trevino; Rhett Schiffman

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12):3021. doi:

ARVO Annual Meeting Abstract September 2016

Extended Release of anti-VEGF Biologics from Biodegradable Hydrogel Implants for the Treatment of Age Related Macular Degeneration

Gary Owens; Melissa Sandahl; Melissa Hernandez; Andres Garcia; Stuart Williams; Tomas Navratil; Rhett Schiffman

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12):527. doi:

ARVO Annual Meeting Abstract September 2016

Completed 28-Day and Ongoing 12-Month Safety and Efficacy Evaluation of ENV515 (travoprost) Intracameral Implant in Phase 2 Study

Thomas R Walters; Tomas Navratil; Stacey Pittman; Virginia Conley; Leo Trevino; Bruce E Silverstein; Michael Depenbusch; Steven L Mansberger; Rhett Schiffman

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12):3025. doi:

ARVO Annual Meeting Abstract September 2016

A 6-Week Toxicity and Toxicokinetics Study of a Single Bilateral Intracameral Administration of ENV905 (difluprednate) Ophthalmic Implant in New Zealand White Rabbits

RiLee Robeson; Rozemarijn S Verhoeven; Andres Garcia; Paul Miller; Jacqueline Miller; Tomas Navratil; Rhett M Schiffman

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12):4013. doi:

ARVO Annual Meeting Abstract September 2016

A 6-Week Ocular Pharmacokinetic Study of ENV905 (difluprednate) Intracameral Implant or Durezol in the Albino Rabbit

Rozemarijn S Verhoeven; RiLee Robeson; Andres Garcia; Brian C Gilger; David Culp; Craig B Struble; Lee Hamm; Thomas Grizzle; Tomas Navratil; Rhett M Schiffman

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12):5711. doi:

ARVO Annual Meeting Abstract June 2015

Interim Results of a Dose Escalation Study of NT-503 Encapsulated Cell Therapy for the Treatment of Choroidal Neovascularization in AMD

Anat Loewenstein; Hugo Quiroz-Mercado; Jose Luis Guerrero-Naranjo; Sergio Rojas; Arturo Santos; Juan Carlos Altamirano; Yael Morales; Rhett Schiffman

Invest. Ophthalmol. Vis. Sci.. 2015; 56(7 ):2277. doi:

ARVO Annual Meeting Abstract June 2015

Proteomic Mass Spectroscopy Profiling of Proteins Secreted from an Encapsulated Cell Technology (ECT) Implant Device

Lisa D. Orecchio; Michael Rivera; Edward Brissette; Cahil McGovern; Arne Nystuen; Rhett Schiffman; Konrad Kauper

Invest. Ophthalmol. Vis. Sci.. 2015; 56(7 ):229. doi:

ARVO Annual Meeting Abstract June 2015

Evaluation of Retinal Structure and Function of Rabbits Following Continuous VEGF Inhibition by Encapsulated Cell Therapy (ECT)

Alline M. A. Lelis; Michael Rivera; Lisa D. Orecchio; Pam Heatherton; Edward Brissette; Alice Lee; Cahil McGovern; Arne Nystuen; Rhett M Schiffman; Konrad Kauper

Invest. Ophthalmol. Vis. Sci.. 2015; 56(7 ):232. doi:

ARVO Annual Meeting Abstract April 2014

Design Considerations and Performance of a Next-Generation Encapsulated Cell Technology Intraocular Implant Delivering VEGF-Antagonist

Konrad Kauper; Michael Rivera; John Mills; Alline Lelis; Megan Billings; Cahil McGovern; Arne Nystuen; Sandy Sherman; Pam Heatherton; Rhett Schiffman

Invest. Ophthalmol. Vis. Sci.. 2014; 55(13):441. doi:

ARVO Annual Meeting Abstract June 2013

Progression of Ocular Findings (PROOF) Study of the Natural History of Dry Eye: Study Design and Baseline Patient Characteristics

Peter McDonnell; Steve Pflugfelder; Rhett Schiffman; David Hardten; Michael Stern; Taryn Conway; David Hollander

Invest. Ophthalmol. Vis. Sci.. 2013; 54(15):4338. doi:

Advertisement